Epidemiology and Risk Factors for HCV Infection Among MSM With or at Risk of HIV in Madrid (2022–2024) - Takeaways - MDSpire

Epidemiology and Risk Factors for HCV Infection Among MSM With or at Risk of HIV in Madrid (2022–2024)

  • By

  • Pablo Ryan

  • Juan Berenguer

  • Luis Ramos-Ruperto

  • Mar Vera

  • Luz Martín-Carbonero

  • Leire Pérez-Latorre

  • Ignacio De los Santos

  • Adriana Pinto

  • María J Vivancos

  • Eva Orviz

  • Beatriz Álvarez

  • José Sanz

  • Pilar Ruiz-Seco

  • Rafael Torres

  • Beatriz Brazal

  • Marta De Miguel

  • Beatriz López-Centeno

  • Inmaculada Jarrín

  • Salvador Resino

  • José M Bellón

  • Juan González-García

  • GeSIDA 12121-CoRIS Cohort 08_2021 ATHENS study group

  • November 6, 2025

  • 0 min

Share

  • 1

    The study enrolled 1372 MSM, including 733 with HIV and 639 on PrEP, to assess HCV epidemiology in Madrid from 2022 to 2024.

  • 2

    Baseline HCV prevalence was 1.68%, significantly higher in MSM with prior HCV exposure at 5.60% compared to 0.72% in those without.

  • 3

    Overall HCV incidence was 1.45/100 person-years, with primary infection incidence at 0.79/100 PY and reinfection incidence at 4.32/100 PY.

  • 4

    Risky sexual behaviors, including slamsex and condomless receptive anal intercourse with multiple partners, were linked to HCV transmission.

  • 5

    Behavior-informed prevention strategies are essential for sustaining HCV elimination efforts among MSM populations in Madrid.

Original Source(s)

Related Content